In the light of the current COVID-19 chaos and keeping in consideration the health of our participants,World BI will now host its Drug Discovery Conferences 2020 virtually. Connect with the Industry professionals while staying safe at home. All you need is an internet connection and an appetite to Learn, Grow & Prosper. So, don’t miss out on the opportunity to learn from industry experts at our events and get yourself
Register Now!
“GVK BIO is a global Contract Research and Development Organization (CRDO) providing research and development services from “Concept to Clinic” to the biopharma and life sciences industry. We enable our customers to bring their products to market in a fast yet cost-efficient manner. GVK BIO employs a no-conflict model and ensures no internal programs that can potentially conflict with our customers projects. Our team of over 2500+ well qualified scientists, backed by rigorous processes, scalable practices, modern facilities and a strong customer-centric partnering approach, makes it India’s leading CRDO.”
“The Cambridge Crystallographic Data Centre (CCDC) are world-leading experts in structural chemistry data, software and knowledge for materials and life science research and application. We specialise in the collation, preservation and application of scientific structural data for use in pharmaceutical discovery, materials development and research and education. We compile and distribute the Cambridge Structural Database (CSD), a certified trusted database of fully curated and enhanced organic and metal-organic structures, used by researchers across the globe. Our cutting-edge software empowers scientists to extract invaluable insights from the vast dataset, informing and accelerating their research & development.”
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue.
Fast track to drugability - through in-vitro biology Attana Research Services are geared to quickly selected the right candidate molecules and targets. We provide you with biologically relevant information on crucial processes occur in the body. Attana is a Swedish company founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Attana develops and sells proprietary label free biosensors for biochemical, crude, sera and cell-based assays as well as contract research services. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences.
Humana Biosciences is a pre-clinical Contract Research Organization (CRO) with leading scientific capabilities in Respiratory, Gastro-Intestinal and Uro-Genital therapeutic areas. Every study they conduct is a custom designed study tailored specifically for the client. Their objective is to offer their customers the best predictive experimental models for chronic functional pathologies. Their ultimate ambition is to make pre-clinical drug development more predictive and faster. Their mission is to reduce the number of inefficacious candidates moving through to the later stages of clinical investigation by developing innovative experimental models (in vitro and in vivo). Partnering with Humana Biosciences also gives you on-demand access to ethically obtained human tissues.
e-Zyvec is a French Biotech Start-up founded in 2016 as a spin-off of the University of Lille 1. We are providing unique solutions in molecular biology to academical or industrial scientists working on research project with genetic engineering applications. Using our proprietary DNA assembly technology and our in-house developped web application, we can design and produce fully customized gene expression vectors, fitting exactly the requirements of your project. Getting vectors with e-zyvec is fast, accurate and unrestrictive.
Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor made ADME-Tox services. Our service offering covers research services for peptides, biologics and small molecules and is widely spread over the whole ADME-Tox area. The right assays are available, whether in the discovery or lead optimisation phase. The level of data interpretation can be customised according to customer preferences. Currently Admescope serves customers in 28 countries on four continents.
AnalytiCon Discovery offers a complete Natural Product (NP) drug discovery solution, ranging from biomaterial acquisition, extraction, fermentation and screening to computational and medicinal chemistry, delivering NP-libraries with fully elucidated structures. AnalytiCon’s programs and collections of pure NPs (MEGAbolite) as well as of semisynthetic NP-analogues (NatDiverse) enable HT-screening of NPs.
evitria specializes in CHO-based transient expression of recombinant antibodies (including bispecific and fusion antibodies) for research purposes. evitria offers fast, cost-effective antibody expression with a flexible scale of production of purified antibody or supernatant according to client needs. Headquartered in Zurich (Switzerland) and founded in 2010. evitria has since performed more than 55,000 transfections and produced more than 10,000 antibodies for its global customer base and excels with its benchmark-setting speed, reliability and quality. In terms of antibody design evitria offers bispecific antibodies, fusion antibodies including Fc fusion proteins, antibody framework switching, Isotype switching, Glyco-engineering, ADCC modulation, chimerisation and humanization. evitria has become one of the leading providers of custom-made recombinant antibodies and services for a broad range of clients from research institutions and start-ups to globally operating biotechnology and biopharmaceutical companies.
Ardigen is a Life Science computational partner in the era of Artificial Intelligence. We provide comprehensive services that leverage our domain knowledge and expertise in bioinformatics, machine learning and software engineering together with our proprietary technology. Ardigen platforms for neoepitope, biomarker, and microbiome research facilitate the improvement of the response rates in immuno-oncology.
Selvita is an integrated service provider aiming to deliver a set of comprehensive solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development.
ChemAxon is a leading cheminformatics company, with headquarters in Budapest, Hungary and offices in the US, they provide chemical software development platforms mostly for the biotechnology and pharmaceutical industries - but any chemist might find us useful. Known for their rapid and high-quality technical support, they develop their tools together with their users (the reason we have good quality software); and because they support academic research and teaching like no one else in the industry! Well, among many other things, you can draw & view chemical structures with Marvin Suite; manage and search your compounds with JChem tools; search your database in Excel or in their Instant JChem interface; perform a variety of calculations and predictions; cluster, screen, fragment or synthesize your compounds virtually and deal with Markush structures.
Sai Life Sciences is built on the bedrock of partnership. They work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Their Vision is to support global innovator partners bring 25 new medicines to life by 2025. And they are well on that journey.
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. They offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines.
MaxWell Biosystems AG provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery. They have built MaxOne, the most powerful electrophysiology platform for recording and stimulating electrogenic cells (brain, retina, and heart cells) in vitro. MaxOne is a CMOS-based high-density microelectrode array with 26,400 electrodes, 1024 low-noise readout channels, and 32 stimulation channels. MaxOne allows extracting single cell and network parameters that facilitate phenotypic screening and drug toxicity/efficacy testing.
Sino Biological is an international reagent supplier and service provider.The company specializes in recombinant antigen production and antibody development.The company’s ever-growing portfolio of products includes recombinant proteins, monoclonal antibodies,ELISA assay kits,expression clones,cell culture media,and other molecular biology tools.The company also offers a variety of customized services,mainly focusing on recombinant production of antigens and antibodies.Sino Biological is dedicated to virology and infectious disease research.Its newly launched ProVirTM collection is the world’s largest viral antigen bank,carrying over 800 products from 350 strains of viruses.
Raffles is a small molecules specialist based in Guangdong China. We support pharma companies from around the world with process development and manufacturing of innovative compounds. Our custom synthesis services (CSS) group is lead by an experienced library builder for med-chem support, and the team is focused on providing scaffolds and libraries of unique compounds to suppoort drug discovery efforts. Specialties include chiral compounds, sulfur containing molecules, and heterocyclics with difficult substitution patterns. We are based in Guangdong China where we operate 45,000 sq. ft of modern, well-equipped lab and production facilities.
ChemPass has developed an integrated end-to-end AI-assisted lead discovery platform that can meaningfully increase the preclinical development success rate, shorten development time, and significantly decrease preclinical development cost. Each component in the platform is carefully optimized to fulfill its key objectives in the process while together as a whole they deliver a unified and powerful AI-platform. As opposed to generative design with deep networks, ChemPass’ unique and highly efficient small molecule design platform uses artificial intelligence for in silico forward organic synthesis resulting in novel lead analogs with valuable practical synthetic feasibility data. Multiple design technologies and other proprietary solutions in docking and ML models have been validated in >40 lead optimization projects in collaboration with big Pharma and biotech partners from the US and EU.
Krishna Kanumuri
CEO
John Shirley
Sr. Director of Sales & Marketing
Dr. Rob Burgess
Chief Business Officer,
I came to Sai Life Sciences from global telecom firm with a finance background to help with business development. It has been a remarkable experience working with all our great partners and being a small part of their success stories. In the 14 years I have been with Sai, it has been great to witness our transformation from a 30 member chemistry services provider to an integrated discovery, development and commercial service provider with over 2,000 employees.
At Sai, we truly focus on our partner’s success. Our fundamental belief is that we can add true investor value by building long terms customer relationships, as opposed looking at profitability at a transactional level. This ensures that we take a long term view of the business over a 10 year horizon, enabling us to make larger investments in the business and offering customers the framework to have a truly collaborative relationship. We are committed to our motto of “Making things better together”.
The rate of innovation is going to accelerate. The real game changer will be the ability of companies to be flexible and aggressive in adopting new technologies and getting products to market faster.
Talent is always a fundamental driver of company’s success. Our challenge will always be to attract and groom the best talent, while creating a supporting environment for them to truly excel.
Discovery Technologies: Placing the right bets on what technologies you want to adopt. Every move involves substantial investment and takes times to implement. This really presents some high risk reward choices companies will have to make.Information Technology: We are in a major transition phase where IT technology will be integral part of how we innovate and how we analyze data. Every company needs to develop the core IT architecture in their organizations now, if they want to stay relevant. Regulatory framework: The regulations are getting much more stringent. How do you stay fast and still ensure minimum regulatory risk.
It is now more critical than ever to stay current and really understand trends in the industry. DDIP is a great place for us to network and keep us at the front end of innovation trends.
www.bio-equip.com was established in the early days of the Internet, in July 1998. Over the last two decades, themed on ¡°serving life sciences and serving high quality suppliers, Bio-equip has provided the users in the fields of life sciences, medicine research, biological pharmacy, bio-engineering, modern agriculture, food safety, environmental monitoring and forensic science with the industrial information in terms of devices and instruments, reagents, consumables, lab animals, cell lines, books, biological R&D service, second-hand instruments and instrument repairs. There are two versions, the Chinese version (bio-equip.com) and English version (bio-equip.cn): So far over 30,000 companies have registered as members and provided over 1 million product entries in the Chinese version (www.bio-equip.com), The daily visits exceed over 60,000.. The English version (www.bio-equip.cn), established in 2006, is the only English website in this field. Until August 2018, over 1,000 companies from both at home and abroad have registered as members, covering the fields of manufacturing, sale and agency of instruments/reagents with over 100,000 product entries.
Industry Events is a leading global platform that helps the world's workforce find relevant business events, learning opportunities and whitepapers in over 350 sectors. Professionals all over the world are using the Industry Events App and website daily to discover high-end professional events to attend or participate in as a speaker, exhibitor or sponsor. Event organizers can self-post (in real-time) their own conference, trade show, expo or convention information for free on the Industry Events website and mobile apps, enabling their professional event, grand or intimate in nature, immediate reach to a relevant global audience of interested professionals.
CanBiotech is an open innovation and patient engagement platform for the biotech and pharmaceutical industries. Visit CanBiotech to learn more about best practices for collaboration with industry stakeholders and patients. Participate in the discussion, attend upcoming events and training opportunities provided by CanBiotech and our partners in the areas of innovation program development, open bioinnovation, design thinking for health and patient engagement.
World conference alerts, is basically an online platform where you can get the details about the conferences, seminars, workshops and other related events.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
Medical events guide(MEG) is a platform that serves as a guide for trusted information about healthcare and medical events worldwide. We not only provide a trusted source for all interested parties to access information about Medical Expos, CME meetings, and Conferences, but also a place for doctors, medical professionals, healthcare investors, device manufacturers, event organizers, and venues to interact with each other. By carefully helping medical companies and doctors access the right events for their selected preferences, MEG wants to ensure that events have the maximum coverage and impact on audiences. Our Vision: Medical events guide is a platform that serves as an online guide for the exceptional and latest information about Medical events happening worldwide. We not only provide you with a vast database of events but also provide a platform for the entire medical industry to come together in one place
Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here ebooks.benthamscience.com. Bentham Science is offering 20% discounts on purchasing eBooks and subscriptions on Journals to delegates attending the conference. TO AVAIL, QUOTE BSPCNF2019 at www.eurekaselect.com or email at marketing@benthamscience.org . For more information visit website
JSB Conference aims at bringing together the key players, building ideas, connections and actions for the community of experts from the leading industries. The focus primarily is to influence the future business and the market. As a digital bridge, JSB Conference associates as Media Partners and assures right audience to set the agenda.
10times is the world's largest aggregator of business events. Trade Shows or Conferences, you name an event and we have it listed. Browse events, roam around and go crazy @10times. We drive massive B2B traffic from across the globe on this single freakishly amazing platform.
Manuscriptedit.com, your online partner for Scientific & academic paper English language editing, proofreading, medical writing, formatting, design & development, and journal publication support services.
Biomat.net is an organized and meaningful Biomaterials and Tissue Engineering communication resource for scientists, researchers, members of the business community, government, academia, and the general public.